Our RA patients, particularly those with moderate-to-severe NAFLD, showed elevated levels of soluble TIM-3 (sTIM-3), which could block membrane-bound TIM-3 expressed on T cells and thus restore proliferation and activation of these immune cells (51). Here, HAVCR2 is linked to metabolic dysfunction-associated steatotic liver disease.